Browsing: Clinical Trials

Eli Lilly’s scope in neuroscience is broadening to psychedelics through a deal to buy AtaiBeckley, a clinical-stage company whose lead…

Advanced cases of breast cancer now have a new FDA-approved treatment option, a Celcuity drug whose first-in-a class approach could…

On April 28, the FDA announced the successful initiation of two real-time clinical trials and released a Request for Information…

Spero Therapeutics, a company whose history in antibiotics research culminated in the recent FDA nod for its first product, is…

GSK has results from a pivotal clinical trial showing rectal cancer patients treated with its drug avoided the need for…

In a Monday letter, 195 patient advocacy, public health and healthcare professional organizations endorsed the Clinical Trial Modernization Act, which…

The cyberattack on Novo Nordisk has become much more than another healthcare data breach. What began as unauthorized access appears…

AstraZeneca’s newest addition to its respiratory pipeline is an inhalable medication that could rival a Merck drug approved for treating…

Bausch + Lomb is dropping plans to develop a drug for glaucoma after the experimental treatment failed a mid-stage clinical…

An RNA therapy from partners Ionis Pharmaceuticals and AstraZeneca failed a pivotal study as a treatment for a type of…